je.st
news
ABRAXANE Phase III Study of Patients with Metastatic Pancreatic...
2013-10-17 14:14:39| Biotech - Topix.net
Celgene International Sarl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine .
Tags: study
iii
phase
patients
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||